Adrian Rawcliffe

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Philadelphia, PA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Adrian Rawcliffe
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Adrian Rawcliffe

Form 4 holding Chief Executive Officer, Director

Adaptimmune Therapeutics PLC

Security class
American Depositary Shares representing Ordinary Shares
Shares / value
44,327
Estimated value
$25,745
Report date
17 Jan 2025
Price
$0.5808
Ownership
Direct
Form 4 holding Chief Executive Officer, Director

Adaptimmune Therapeutics PLC

Security class
Option to purchase Ordinary Shares
Shares / value
3,428,832
Estimated value
Report date
20 Feb 2025
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Insider Reports Filed by Adrian Rawcliffe

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .